Dr Campbell main stake is IP, his name's listed as the co-author on most of the patents so you'd think that it isn't just dilution that he's trying to avoid: he has a lot to gain as the beneficiary of royalties if they can make it work.....I only wish that they wouldn't had this current "make or brake" scenario get so damn ominous.
Ann: Presentation to highlight broader potential of Deoxymabs, page-49
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.46M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.8¢ | 0.7¢ | $23.67K | 2.969M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 7454700 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 1660014 | 3 |
View Market Depth
| Last trade - 15.08pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.7¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.7¢ | 0.8¢ | 0.7¢ | 1995477 | ||
| Last updated 15.42pm 28/05/2024 ? | |||||
| PAB (ASX) Chart |